Stocks yielding high dividends and posting historical dividend performance are sure to be on the radars of investors

Gilead Sciences (GILD) has a current portfolio dominated by HIV treatment drugs.

With a market capitalization under $650 million, MHLD is well positioned for significant growth.

Ever since the economic meltdown of 2008, investors have viewed financial firms in a different light.